Hepatitis A medical therapy: Difference between revisions
Undo revision 649324 by Daniel Nethala (talk) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Hepatitis A}} | {{Hepatitis A}} | ||
{{CMG}}; {{AOEIC}} {{VK}} | {{CMG}}; {{AOEIC}} {{VK}} | ||
==Overview== | |||
==Treatment== | ==Treatment== | ||
Revision as of 15:05, 18 June 2012
|
Hepatitis A |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis A medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatitis A medical therapy |
|
Risk calculators and risk factors for Hepatitis A medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Overview
Treatment
Hepatitis A is a self-limiting infection. There is no specific treatment but for supportive care. Patients are advised to rest, avoid fatty foods and alcohol (these may be poorly tolerated for some additional months during the recovery phase and cause minor relapses), eat a well-balanced diet, and stay hydrated. Approximately 15% of people diagnosed with hepatitis A may experience one or more symptomatic relapse(s) for up to 24 months after contracting this disease. Patients who develop fulminant hepatitis may require aggressive supportive therapy, and be transferred to a center capable of performing liver transplantation.